These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 18192847)

  • 1. Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
    Pu Q; Brassard P; Javeshghani DM; Iglarz M; Webb RL; Amiri F; Schiffrin EL
    J Hypertens; 2008 Feb; 26(2):322-33. PubMed ID: 18192847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of simvastatin given alone and in combination with valsartan or enalapril on blood pressure and the structure of mesenteric resistance arteries and the basilar artery in the genetically hypertensive rat model.
    Ledingham JM; Laverty R
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):76-85. PubMed ID: 15730439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of glitazones on blood pressure and vascular structure in mesenteric resistance arteries and basilar artery from genetically hypertensive rats.
    Ledingham JM; Laverty R
    Clin Exp Pharmacol Physiol; 2005 Nov; 32(11):919-25. PubMed ID: 16405447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effects of AT1 receptor blockade provide end-organ protection in stroke-prone rats independently from blood pressure fall.
    Sironi L; Gelosa P; Guerrini U; Banfi C; Crippa V; Brioschi M; Gianazza E; Nobili E; Gianella A; de Gasparo M; Tremoli E
    J Pharmacol Exp Ther; 2004 Dec; 311(3):989-95. PubMed ID: 15302895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat.
    Hegde LG; Yu C; Renner T; Thibodeaux H; Armstrong SR; Park T; Cheruvu M; Olsufka R; Sandvik ER; Lane CE; Budman J; Hill CM; Klein U; Hegde SS
    J Cardiovasc Pharmacol; 2011 Apr; 57(4):495-504. PubMed ID: 21297495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
    Lassila M; Davis BJ; Allen TJ; Burrell LM; Cooper ME; Cao Z
    Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II/AT2 receptor-induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinase.
    Savoia C; Ebrahimian T; He Y; Gratton JP; Schiffrin EL; Touyz RM
    J Hypertens; 2006 Dec; 24(12):2417-22. PubMed ID: 17082724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of combination of valsartan and amlodipine on salt-induced brain injury in hypertensive rats.
    Dong YF; Kataoka K; Tokutomi Y; Nako H; Nakamura T; Toyama K; Sueta D; Koibuchi N; Yamamoto E; Ogawa H; Kim-Mitsuyama S
    J Pharmacol Exp Ther; 2011 Nov; 339(2):358-66. PubMed ID: 21807884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
    Esnault VL; Ekhlas A; Nguyen JM; Moranne O
    Nephrol Dial Transplant; 2010 Jul; 25(7):2218-24. PubMed ID: 20106824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of combination of valsartan with benazepril on blood pressure and left ventricular hypertrophy in SHR.
    Ke YS; Cao H; Yang T
    Acta Pharmacol Sin; 2000 Nov; 21(11):1043-7. PubMed ID: 11501062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II type 1 receptor antagonist and angiotensin-converting enzyme inhibitor altered the activation of Cu/Zn-containing superoxide dismutase in the heart of stroke-prone spontaneously hypertensive rats.
    Tanaka M; Umemoto S; Kawahara S; Kubo M; Itoh S; Umeji K; Matsuzaki M
    Hypertens Res; 2005 Jan; 28(1):67-77. PubMed ID: 15969257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective effect of angiotensin II type 1 receptor antagonist associated with bradykinin-endothelial nitric oxide synthase and oxidative stress in Dahl salt-sensitive hypertensive rats.
    Yoshida K; Kobayashi N; Ohno T; Fukushima H; Matsuoka H
    J Hypertens; 2007 Aug; 25(8):1633-42. PubMed ID: 17620960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 2nd communication: valsartan prevents end-organ damage in spontaneously hypertensive stroke-prone rats during 1-year treatment.
    Kometani M; Hayashi N; Yamamoto S; Nakao K; Inukai T
    Arzneimittelforschung; 1997 May; 47(5):613-9. PubMed ID: 9205774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excess salt causes cerebral neuronal apoptosis and inflammation in stroke-prone hypertensive rats through angiotensin II-induced NADPH oxidase activation.
    Yamamoto E; Tamamaki N; Nakamura T; Kataoka K; Tokutomi Y; Dong YF; Fukuda M; Matsuba S; Ogawa H; Kim-Mitsuyama S
    Stroke; 2008 Nov; 39(11):3049-56. PubMed ID: 18688015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olmesartan reduces oxidative stress in the brain of stroke-prone spontaneously hypertensive rats assessed by an in vivo ESR method.
    Araki S; Hirooka Y; Kishi T; Yasukawa K; Utsumi H; Sunagawa K
    Hypertens Res; 2009 Dec; 32(12):1091-6. PubMed ID: 19763130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats.
    Pu Q; Touyz RM; Schiffrin EL
    J Hypertens; 2002 May; 20(5):899-907. PubMed ID: 12011651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
    Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined angiotensin II AT1-receptor blockade and angiotensin I-converting enzyme inhibition on survival and cardiac remodeling in chronic heart failure in rats.
    Richer C; Fornes P; Domergue V; De Gasparo M; Giudicelli JF
    J Card Fail; 2001 Sep; 7(3):269-76. PubMed ID: 11561229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 1st communication: antihypertensive effects of valsartan in hypertensive models.
    Yamamoto S; Hayashi N; Kometani M; Nakao K; Inukai T
    Arzneimittelforschung; 1997 May; 47(5):604-12. PubMed ID: 9205773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II Receptor-Neprilysin Inhibitor Sacubitril/Valsartan Improves Endothelial Dysfunction in Spontaneously Hypertensive Rats.
    Seki T; Goto K; Kansui Y; Ohtsubo T; Matsumura K; Kitazono T
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.